Course handouts are now available
Click here
Come to London
WATCH to find out why
Site updates:
Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.
Posters
(results will display both Free Papers & Poster)
Risk factors of disease progression after cataract surgery in chronic angle-closure glaucoma patients
Poster Details
First Author: C.Lee SOUTH KOREA
Co Author(s): C. Kim D. Kim
Abstract Details
Purpose:
To evaluate clinical risk factors of disease progression after cataract surgery, phacoemulsification with posterior chamber intraocular lens (PCIOL) implantation, in eyes with chronic angle-closure glaucoma (CACG) and coexisting cataract.
Setting:
Clinical practice
Methods:
Setting: clinical practice
Study Population: The data of 56 eyes of 45 CACG patients who had undergone uncomplicated phacoemulsification with PCIOL implantation were retrospectively analyzed. Observational Procedures
Main Outcome Measures: Disease progression, Correlations between VF progression and various pre- and postoperative factors
Results:
Mean postoperative follow-up period was 45.13 ± 17.54 (24-84) months. Fourteen eyes (25%) with cataracts diagnosed with CACG progressed after phacoemulsification, but the remaining 42 eyes (75%) did not. According to univariate analysis, disease progression was significantly associated with older age, more number of pre-/postoperative antiglaucoma drugs, higher scores of preoperative pattern standard deviation, and lower scores of pre- and postoperative visual field index (VFI)( P<0.05). Using multivariate analysis, a lower score of preoperative VFI (OR: 0.86, P=0.044), and lower postoperative intraocular pressure (IOP) reduction which was not sustained below 20% less than preoperative mean IOP were significantly correlated with disease progression after cataract surgery (OR: 8.44, P=0.048).
Conclusions:
CACG patients with low preoperative VFI and high postoperative IOP are at risk of disease progression even after uncomplicated cataract surgery. FINANCIAL INTEREST: NONE